By extrapolation from the responses of cultured human umbilical vein e
ndothelial cells (EC) and bovine aortic EC to short-term cytokine stim
ulation, EC activation is postulated as a likely component of the host
response in acute allograft rejection and cardiac transplant-associat
ed accelerated arteriosclerosis, To investigate the extent to which EC
activation occurs in vivo in humans and to identify potential targets
for therapeutic interventions, we compared the phenotypic characteris
tics of vascular EC as seen during clinicopathologically significant v
s non-significant acute cardiac allograft rejection. We used monoclona
l and monospecific polyclonal antibodies to coagulation molecules [tis
sue factor, thrombomodulin (TM), antithrombin III fibrinogen/fibrin, c
ross-linked fibrin and von Willebrand factor (vWF)], adhesion molecule
s (P-selectin, ICAM-1) and major histocompatibility complex (MHC) clas
s I and II molecules, In addition we sought evidence of local cytokine
production (IL-l, IL-2R, IL-4, IL-6, IL-7, IL-8, TNF-alpha, PDGF-AA,
PDGF-BB), which might mediate alterations in expression of these prote
ins. We found that in clinically significant grades of cardiac allogra
ft rejection requiring increased immunosuppression, in contrast to les
ser grades of rejection not requiring clinical intervention, there was
increased microvascular EC activation and differential expression of
cytokines. EC changes associated with more extensive cardiac allograft
rejection requiring treatment included: (i) disruption of the normal
anticoagulant state with downregulation of TM and AT-III, upregulation
of tissue factor and vWF expression, and associated extensive fibrin
deposition; (ii) upregulation of MHC class I antigens, which are poten
tial targets for host cytotoxic T lymphocytes; (iii) increased express
ion of the leucocyte adhesion molecules P-selectin and ICAM-1; (iv) ex
pression of the pro-inflammatory cytokines IL-1 beta and TNF-alpha; an
d (v) increased expression of PDGF-AA and BE, which are known to promo
te migration and proliferation of intimal cells, and hence may contrib
ute to development of transplant-associated atherosclerosis. Collectiv
ely these findings suggest that im mune events resulting in EC surface
changes and/or production of key cytokines play a role in the pathoge
nesis of acute transplant rejection and may contribute to the long-ter
m complication of accelerated arteriosclerosis in allograft coronary a
rteries.